Effect of anti-mouse CD52 monoclonal antibody on mouse intestinal intraepithelial lymphocytes

Transplantation

Volumn 88, Issue 6, 2009, Pages 766-772

  Qu, Linlin ^a,b   Li, Qiurong ^a,b   Jiang, Haitao ^a,b   Gu, Lili ^b   Zhang, Qiang ^a,b   Wang, Chenyang ^b   Li, Jieshou ^a,b  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Antibody target therapy; Intestinal barrier function; Intestinal T cells; Mucosal immunology; Surgical complications

Indexed keywords

ALEMTUZUMAB; LACTULOSE; MANNITOL; NITROBLUE TETRAZOLIUM; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL ISOLATION; CELL TYPE; CELL VIABILITY; COLON; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HISTOPATHOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINAL INTRAEPITHELIAL LYMPHOCYTE; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; LYMPHOCYTE; LYMPHOCYTE DEPLETION; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, NEOPLASM; APOPTOSIS; CELL SURVIVAL; EPITHELIUM; GLYCOPROTEINS; IMMUNITY, MUCOSAL; INJECTIONS, SUBCUTANEOUS; INTESTINES; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; PERMEABILITY; TRANSPLANTATION IMMUNOLOGY;

EID: 70350525054     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b47c61     Document Type: Article

References (40)

1. Kirchhoff C, Hale G. Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Mol Hum Re-prod 1996; 2: 177.
2. Hale G, Bright S, Chumbley G, et al. Removal of T cells from bone marrow for transplantation: A monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873.
3. Hale G, Xia MQ, Tighe HP, et al. The CAMPATH-1 antigen (CDw52). Tissue Antigens 1990; 35: 118.
4. Villamor N, Montserrat E, Colomer D. Mechanism of action and resistance to monoclonal antibody therapy. Semin Oncol 2003; 30: 424.
5. Garcia M, Weppler D, Mittal N, et al. Campath-1H immunosuppres-sive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004; 36: 323.
6. Shapiro R, Ellis D, Tan HP, et al. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007; 7: 2736.
7. Stanglmaier M, Reis S, Hallek M. Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines andinchronic lymphocytic leukemia cells. Ann Hematol2004; 83: 634.
8. Kubota H, Okazaki H, Onuma M, et al. Identification and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes. Down-regulation by lymphocyte activation. J Immunol 1990; 145: 3924.
9. Ito K, Hasegawa A, Komori S, et al. Biochemical property and immu-nogenicity of mouse male reproductive tract CD52 (mrt-CD52). J Re-prod Immunol 2007; 75: 32.
10. Kirchhoff C. A major messenger ribonucleic acid of the rodent epidid-ymis encodes a small glycosylphosphatidylinositol-anchored lymphocyte surface antigen. Biol Reprod 1994; 50: 896.
11. Lepage AC, Buzoni-Gatel D, Bout DT, et al. Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii. J Immunol 1998; 161: 4902.
12. Inagaki-Ohara K, Dewi FN, Hisaeda H, et al. Intestinal intraepithelial lymphocytes sustain the epithelial barrier function against Eimeria ver-miformis infection. Infect Immun 2006; 74: 5292.
13. Martin SI, Marty FM, Fiumara K, et al. Infectious complications associated with alemtuzamab use for lymphoproliferative disorders. Clin Infect Dis. 2006; 43: 16.
14. Heider U, Fleissner C, Zavrski I, et al. Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection. Eur J Haematol 2004; 72: 64.
15. Montufar-Solis D, Klein JR. An improved method for isolating intra-epithelial lymphocytes (IELs) from the murine small intestine with consistently high purity. J Immunol Methods 2006; 308: 251.
16. Blood J, Ingle AR, Allison N, et al. Rapid enzymatic method for the measurement of mannitol in urine. Ann Clin Biochem 1991; 28: 401.
17. Vivas S, de Morales JMR, Ramos F, et al. Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. N Engl J Med 2006; 354: 2514.
18. Hale G, Rye PD, Warford A, et al. The glycosylphosphatidylinositol- anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa. J Reprod Immunol 1993; 23: 189.
19. TreumannA, LifelyMR, Schneider P, et al. Primary structure of CD52. J Biol Chem 1995; 270: 6088.
20. Schroter S, Derr P, Conradt HS, et al. Male-specific modification of human CD52. J Biol Chem 1999; 274: 29862.
21. Kirchhoff C, Krull N, Pera I, et al. A major mRNA of the human epididymal principal cells, HE5, encodes the leucocyte differentiation CDw52 antigen peptide backbone. Mol Reprod Dev 1993; 34: 8.
22. Loisel S, Ohresser M, Pallardy M, et al. Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. Crit Rev Oncol Hematol 2007; 62: 34.
23. Tone M, Nolan KF, Walsh LA, et al. Structure and chromosomal location of mouse and human CD52 genes. Biochim Biophys Acta 1999; 1446: 334.
24. Uchida J, Hamaguchi Y, Oliver JA, et al. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 2004; 199: 1659.
25. Hasegawa M, Hamaguchi Y, Yanaba K, et al. B lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006; 169: 954.
26. Kirchhoff C. CD52 is the 'major maturation-associated' sperm membrane antigen. Mol Hum Reprod 1996; 2: 9.
27. Sakuragi J, Sakuragi S, Ohishi M, et al. A rapid recombination assay of HIV-1 using murine CD52 as a novel biomarker. Microbes Infect 2008; 10:396.
28. Dalton JE, Cruickshank SM, Egan CE, et al. Intraepithelial gammad-elta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. Gastroenterology 2006; 131: 818.
29. Hayday A, Theodoridis E, Ramsburg E, et al. Intraepithelial lymphocytes: Exploring the Third Way in immunology. Nat Immunol 2001; 2:997.
30. Domagala A, Kurpisz M. CD52 antigen-A review. Med Sci Monit 2001; 7: 325.
31. Ehrhardt RO, Strober W, Harriman GR. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation. J Immunol 1992; 148: 3830.
32. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994; 266: 1253.
33. Bryson JS, Zhang L, Goes SW, et al. CD4+ T cells mediate murine syngeneic graft-versus-host disease-associated colitis. J Immunol 2004; 172: 679.
34. Smit-McBride Z, Mattapallil JJ, McChesney M, et al. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4( +) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J Virol 1998; 72: 6646.
35. McDonald V, Robinson HA, Kelly JP, et al. Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect Immun 1996; 64: 2556.
36. Holger Nuckel UHF, Alexander Roth UD, Siffert W. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity. Eur J Pharmacol 2005; 514: 217.
37. Goteri G, Rupoli S, Tassetti A, et al. Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma. Ann Hematol 2006; 85: 617.
38. Sukkar SG, Schenone E, Foppiani L, et al. Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test. Tumori 2004; 90: 461.
39. Dombrowicz D, Nutten S, Desreumaux P, et al. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med 2001; 193: 25.
40. Kennedy GA, Seymour JF, Wolf M, et al. Treatment of patients with advanced mycosis fungoides and Sezary syndrome with alemtuzumab. Eur J Haematol 2003; 71: 250.